Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter
-
Akebia Therapeutics Announces Multiple Positive Business Updates
-
ORYZON Announces First Patient Dosed in NCI-Sponsored Iadademstat in Combination With Venetoclax and Azacitidine Clinical Trial in First Line Acute Myeloid Leukemia
-
JND Names Scott Lombard Executive Vice President
-
RELEX Solutions Positioned as a Leader in the IDC MarketScape: Worldwide Retail AI-driven Assortment Planning Solutions 2025 Vendor Assessment
-
Algolia Introduces ‘Shopping Guides’: A Generative AI Tool to Elevate the Online Shopping Experience
-
Leading Global Healthtech - Proximie - Completes a Stellar Year of Growth
-
Really Great Reading Recognized by The Reading League for Excellence in Literary Instruction
-
American Eagle Outfitters Raises Fourth Quarter Profit Outlook; Holiday Sales Above Expectations with Growth Across Brands
-
VEON to List Kyivstar on Nasdaq in New York, Signs Letter of Intent with Cohen Circle
-
ILHA's INSPIRE Conference Sets New Benchmark for Luxury Hospitality Innovation
-
Pioneer Energy Partners with Emvolon, Selected by Department of Energy for a $6 Million Grant for Flare Gas to Methanol Technology
-
Spyre Therapeutics Highlights 2025 Priorities and Robust Pipeline of Upcoming Clinical Readouts
-
With Technological Accumulation as the Axis and Brand Execution as the Core, THUNDEROBOT Debuts at CES 2025
-
Pediatrics Plus Partners with Leavitt Equity Partners for Next Phase of Growth
-
KTrust Uncovers Critical Security Vulnerability in Kubernetes, Exposing Enterprise Cloud Applications to Risk
-
Schwab Asset Management to Launch the Schwab Core Bond ETF
-
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
-
hc1 Completes $6.25 Million Funding Round
-
OrthoNebraska Selects Health Catalyst Ignite™ to Advance Data-Driven Orthopedic Care
-
Slate Asset Management Promotes Steven Dejonckheere to Managing Director
-
Next-Gen Toshiba Printers Elevate Industrial Barcode Labeling
-
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
-
STL Announces Self-Certification of its Build America Buy America (BABA/BEAD)-compliant Optical Products
-
Hexagon US Federal Announces Elliott Ferguson as COO
-
Save A Lot Donates Over 67,000 Bags of Food to Charities Across the Country
-
Bentley Systems Welcomes James Lee as Chief Operating Officer
-
With Technological Accumulation as the Axis and Brand Execution as the Core, THUNDEROBOT Debuts at CES 2025
-
Jabra Unveils Perform 75, a Purpose-Built Headset for Retail Shiftwork to Boost Collaboration and Productivity
-
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials
-
American Rebel Holdings CEO Andy Ross Performs at Legendary Whiskey Jam Showcase
-
Rezolve Ai Poised for Global Growth as it enters 2025 with Strong Customer Acquisitions, Strategic Partnerships, and Groundbreaking Innovations
-
Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
SRIVARU Limited Holding Announces Effective Time of Share Consolidation/Reverse Share Split to Regain NASDAQ Compliance
-
Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer
-
Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases
-
Annexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year
-
Immunovant Announces $450 Million Private Placement
-
Iantrek Announces First Commercial Cases of its C.Rex Micro-Interventional System for Trabecular Outflow Enhancement
-
BRAEMAR HOTELS & RESORTS DECLARES DIVIDENDS FOR THE FIRST QUARTER OF 2025
-
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results
-
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference
-
89bio Provides Business Update and Outlook for 2025
-
ARS Pharmaceuticals Announces Preliminary Fourth Quarter 2024 Financial Results and 2025 Objectives for neffy® (epinephrine nasal spray)
-
Extendicare Announces Timing of 2024 Fourth Quarter Results and Conference Call
-
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
-
Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement
-
Vital Farms on Track to Deliver Strong Growth in 2025 with Key Investments in Resilient Supply Chain and Farm Network Expansion
-
Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update
-
Apollo to Acquire Argo Infrastructure Partners
